Vaccination guidance

Nephrada · IgA nephropathy

MI-2026-0287UrgentClosedWithin SLASafety

FAFatima Al-SayedMedical Information Lead

Restricted — potential adverse event

Access limited to Medical Information and Safety roles. Details are captured minimally and routed to pharmacovigilance per SOP-PV-014. AI features are disabled for this record (PRD §27.7).

Received: 25 Mar 2026, 13:55 UTC
Channel: Phone
Requestor type: HCP
Country / region / team: United States · North America · MI Americas
Category: Safety
Response type: Standard response
Owner: FAFatima Al-Sayed
Due: 27 Mar 2026, 13:55 UTC
Responded: 25 Mar 2026, 23:55 UTC
Quality review: Not required
Related insight: —
Related standard response: SR-NPH-005 · Vaccination guidance (v1)

Workflow

12-stage inquiry workflow (PRD §16). Advancing records an audit event.

Received
Triage
Assigned
In progress
Escalated
Draft response
Medical review
Quality review
Sent
Follow-up required
11Closed
12Archived

Current stageClosedDemo action — not persisted

SLA

Urgent: 48 h target · Routine 120 h / Urgent 48 h / Critical 24 h

SLA hours

Elapsed

10 h

to response

Remaining

38 h

21%

Timeline

25 Mar 2026, 13:55 UTC
Received via Phone
HCP · United States
25 Mar 2026, 13:55 UTC
Triage and assignment
Urgency Urgent · assigned to MI Americas
25 Mar 2026, 23:55 UTC
Response sent
Standard response · quality review not required
27 Mar 2026, 13:55 UTC
SLA due (48 h)

Draft response

Restricted record

AI suggestion disabled — safety-flagged inquiries are not interpreted by AI (PRD §27.7).

Draft response

Audit history

No audit events for this record

Create, update, approve and export events appear here with user, timestamp, previous and new values.

Data lineage: MI inquiry platform (IRMS, INT-05) · received 25 Mar 2026 · hourly sync.